$MCIG Announces Agreement With Green Leaf Farms

mCig’s Grower Services Division “GSD” (OTC PINK: MCIG) and Players Network (OTC PINK:PNTV) announces today that it has entered into an agreement to develop for Players Network subsidiary Green Leaf Farms, a large scale 26,000 sq. ft. cultivation and production facility in North Las Vegas, Nevada. Green Leaf has made a deposit for the design and build out of a phased out plan designed to grow with the Nevada Medical Marijuana market.

“mCig is excited about our recent successes on the West Coast. The Green Leaf Farms project will be our third fully customized facility using mCig’s proprietary SIP panel construction for large scale growers,” says Jori Olson VP of GSD Sales. “Recent states to permit medical use have new cultivators looking for knowledgeable construction personnel to perfectly understand their needs, and we are filling that space. The mCig construction team’s knowledge and experience provides for fast and more economical construction compared to local contractors trying to break into the Cannabis space. mCig has invested heavily in servicing growers with construction expertise.”

mCig’s CEO Paul Rosenberg added, “We are very excited to work on this project with the Green Leaf team, they have an incredible vision and want to set the bar high by pushing the limits in the development of a cultivation facility.”

“The mCig system will provide Green Leaf Farms facility super high-tech clean cultivation rooms with a modern look that houses perfect grow environments at a cost much less than traditional construction and quicker speed to market. This backdrop will make great content for our television series and it will become the facility to watch in Las Vegas,” said Mark Bradley CEO of Green Leaf Farms and Players Network.

Bradley added, “We are also very excited to announce that the entire process of building the Green Leaf Farms facility by mCig is being filmed by our subsidiary, WeedTV, to be featured as part of a documentary series.”

About mCig, Inc.:
Headquartered in Henderson, NV, mCig, Inc. (OTCQB: MCIG) is a leading provider of advanced technologies and solutions to the global cannabis industry. mCig manufactures and markets best-selling portable and home vaporizers, extraction related equipment, CBD Rich Hemp Oil-derived products, and related nutraceuticals based on natural compounds found in Cannabis and Hemp plants. The company owns the mCig and Vapolution brands, and has a 47% stake in VitaCig (VTCQ), makers of the VitaStik, a disposable vitamin vaporizer. The company believes that a well-regulated marijuana industry is emerging as more states follow the lead of Alaska, Colorado, Oregon, and Washington in legalizing marijuana. A similar trend is developing within the CBD and Hemp industries following overwhelming consumer demand.

About Player’s Network:
Player’s Network is a diversified company with holdings in both Media and Medical Marijuana. The Company uses its proprietary Enterprise Web Platform to develop Branded Digital Lifestyle Television Networks for itself and its partners in a wide range of lifestyle categories. Player’s Network’s current original channels, “Player’s Network”, “Vegas on Demand”, “Real Vegas TV”, focus on the Las Vegas and Gaming Lifestyles. These channels are distributed over PNTV’s owned and operated VOD Channels over its Broadband Network and Mobile Platforms. The Medical Marijuana assets are primarily through the Company’s 80% ownership in Greenleaf Farms Holdings, and PNTV’s newest channel, “WeedTV.com,” which focuses on the rapidly expanding cannabis community. For more information please visit www.playersnetwork.com.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.